Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells

Documenti analoghi

• Complementary Antiviral Efficacy of Hydroxyurea and Protease Inhibitors in Human Immunodeficiency Virus-Infected Dendritic Cells and Lymphocytes
  di: Piccinini, Giampiero, et al.
  Pubblicazione: (2002)
• Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells
  di: VanCompernolle, Scott E., et al.
  Pubblicazione: (2005)
• Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8(+) and CD4(+) T-Cell Responses
  di: Lopes, Luciene, et al.
  Pubblicazione: (2008)
• Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses
  di: Buonaguro, L., et al.
  Pubblicazione: (2006)
• Dendritic cells and tumor microenvironment: a dangerous liaison: Dendritic cells and tumor microenvironment
  di: Fricke, Ingo, et al.
  Pubblicazione: (2006)